autologous urine-derived mesenchymal stem cell therapy (EHL Bio)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameautologous urine-derived mesenchymal stem cell therapy (EHL Bio)
Drug Alias NameKDSTEMKDSTEM Inj
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionKlotho modulatorsStem cells modulators
TargetsKlotho
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEhl Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEhl Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A